Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:16 UTC
  • 0
  • 1 comments

Day Lucy 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 ($3.7M) Transaction Date: Mar 19, 2026 | Filing ID: 120236

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:16 UTC
  • 0
  • 1 comments

Chanda Sanjay 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 ($2.9M) Transaction Date: Mar 19, 2026 | Filing ID: 120235

Comment Full text

ATLANTICUS HOLDINGS CORP (ATLCP)

  • SEC News
  • March 23, 2026, 23:16 UTC
  • 1
  • 1 comments

Director Howard Jeffrey A. 🟡 adjusted position in 73.8K shares of Atlanticus Holdings Corp (ATLC) at $54.67 Transaction Date: Mar 19, 2026 | Filing ID: 009474

Comment Full text

ATLANTICUS HOLDINGS CORP (ATLCP)

  • SEC News
  • March 23, 2026, 23:16 UTC
  • 1
  • 1 comments

McCamey William 🟡 adjusted position in 18.2K shares of Atlanticus Holdings Corp (ATLC) at $54.67 Transaction Date: Mar 19, 2026 | Filing ID: 009473

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:13 UTC
  • 1
  • 1 comments

Marks Gilbert Lynn 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120230

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:11 UTC
  • 1
  • 1 comments

Aziz Kabeer 🟡 adjusted position in 0 shares (4 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120226

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:10 UTC
  • 1
  • 1 comments

Martin Patricia A. 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120223

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:09 UTC
  • 1
  • 1 comments

FitzPatrick Margaret M 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $18.24 Transaction Date: Mar 19, 2026 | Filing ID: 120221

Comment Full text

ACI WORLDWIDE, INC. (ACIW)

  • SEC News
  • March 23, 2026, 23:09 UTC
  • 1
  • 1 comments

Director deBeers Kimberly A. 🟢 acquired 1.6K shares of ACI WORLDWIDE, INC. (ACIW) Transaction Date: Mar 19, 2026 | Filing ID: 000009

Comment Full text

AN2 THERAPEUTICS, INC. (ANTX)

  • SEC News
  • March 23, 2026, 23:08 UTC
  • 1
  • 1 comments

Wong Stephanie 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120216

Comment Full text
  • Previous
  • 198
  • 199
  • 200
  • 201
  • 202
  • Next

Search

News categories

  • Technical Exchange News(11407)
  • Event(3046)
  • SEC News(209134)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135532)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin